A genetic disease prioritization platform for gene therapy studies: A wide-ranging review
dc.rights.license | CC-BY-NC-ND | |
dc.contributor.advisor | Fuchs, Sabine | |
dc.contributor.author | Schürmann, Paul | |
dc.date.accessioned | 2023-07-22T00:02:01Z | |
dc.date.available | 2023-07-22T00:02:01Z | |
dc.date.issued | 2023 | |
dc.identifier.uri | https://studenttheses.uu.nl/handle/20.500.12932/44270 | |
dc.description.sponsorship | Utrecht University | |
dc.language.iso | EN | |
dc.subject | This review explores the challenge of treating over 10,000 global genetic disorders by targeting their root cause; DNA mutations. Using CRISPR technology as a basis for treating genetic diseases, we review publicly available databases and CRISPR gene editing prediction algorithms for their suitability to screen for diseases with the correct technical, medical and ethical properties that could be considered for gene correction therapy. | |
dc.title | A genetic disease prioritization platform for gene therapy studies: A wide-ranging review | |
dc.type.content | Master Thesis | |
dc.rights.accessrights | Open Access | |
dc.subject.courseuu | Drug Innovation | |
dc.thesis.id | 19867 |